The Mast Cell Receptor MRGX2 and Drug-Induced Anaphylaxis
In a recent webinar Dr. Andrew J Brown, Research Fellow, GSK, presented a compelling narrative on the pharmacological characterization of the MRGX2... Read More
Five Reasons to Implement In Vitro Phenotypic Screening in Preclinical Safety
Reason 1 – Animals Aren’t Predictive of Humans Rodents, in particular, are small, do not live long, and are typically housed in... Read More
3 Great Webinars: Safety, Toxicology, and Combination Therapies
This is a great time to learn about breakout technologies in phenotypic drug development. Here is a short list of some great... Read More